Biodelivery Sciences International Profit Margin

Biodelivery Sciences International posts a profit margin of 50.9% as of December 2021. That compares with 16.43% in the prior-year period — up 209.8% year over year. That is above the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Biodelivery Sciences International's profit margin was 16.43%. The latest reading is 50.9% — a 209.8% year-over-year increase (period ending December 2021). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. Biodelivery Sciences International's 50.9% is higher that level. That is roughly 266.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Biodelivery Sciences International's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 50.9% as of December 2021; use YoY and peer views to separate noise from signal.

Context for BDSI's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Biodelivery Sciences International's other metric pages and overview cover the third.